Analyzing Biometric Impact of Stellate Ganglion Block (SGB)
A new study sponsored by the University of Queensland in partnership with Stella and WHOOP is currently accepting new applicants to be treated in Chicago.
This observational study will examine the psychological and physiological effects of the Stellate Ganglion Block (SGB) procedure and seek to measure to what extent the SGB treatment reduces trauma-related symptoms and improves overall biometric health outcomes.
Tracking SGB Results Through Biometrics
Participants will wear a WHOOP wearable band for 8 weeks to calibrate and measure changes in physiological response to Stella’s SGB treatment protocol, called the Dual Sympathetic Reset. This protocol, developed by Dr. Eugene Lipov, involves two injections into a group of nerves on one side of the neck compared to many other providers who only do a single injection into one nerve bundle.
The WHOOP band will continuously measure sleep quality, heart-rate variability, and resting heart-rate, among other biometric indicators.
All participants will receive a free WHOOP strap and 6-month membership, and receive a $250 rebate from Stella on the cost of their treatment. Throughout the study, participants will be asked questions about their mental health and stress symptoms while the WHOOP strap monitors sleep and heart rate.
Why This Matters
Participants will be contributing to important research with the potential to expand the universe of access to SGB treatment for trauma/PTSD.
Studies like this help further evidence that integrates psychological outcomes and biometric health data to better understand the degree to which SGB treatment impacts sleep and trauma-related symptoms.
To find out if you qualify for the study, call us at 908-928-4086.